Basic Information
| LncRNA/CircRNA Name | LINC01234 |
| Synonyms | NA |
| Region | GRCh38_12:113679459-113773683 |
| Ensemble | ENSG00000249550 |
| Refseq | NR_110026 |
| Regulatory Mechanism | Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Information of Cancer
| Cancer Name | colon cancer |
| ICD-0-3 | C18 |
| Methods | qPCR, Luciferase reporter assay, Western blot |
| Sample | colon cancer tissues, cell lines (HT29, LoVo, SW480, NCM460, HCT116) |
| Expression Pattern | up-regulated |
| Function Description | We found that LINC01234 expression was significantly upregulated in colon cancer tissues and was associated with a shorter survival time. |
| Pubmed ID | 30755591 |
| Year | 2019 |
| Title | Long noncoding RNA LINC01234 promotes serine hydroxymethyltransferase 2 expression and proliferation by competitively binding miR-642a-5p in colon cancer. |
External Links
| Links for LINC01234 | GenBank HGNC Noncode |
| Links for colon cancer | Omim Cosmic |